OMICS International Organises 3000+ Global Conferenceseries Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
For more Conferences visit www.conferenceseries.com

Back

Robert P Bowser

Robert P Bowser

Iron Horse Diagnostics, Inc.

Director

Biography

Dr. Bowser is Chairman of Neurobiology and Director of the Gregory W. Fulton ALS and Neuromuscular Research Center at the Barrow Neurological Institute and St. Joseph's Hospital and Medical Center in Phoenix, AZ. He obtained his PhD from Yale University School of Medicine and was a faculty member at the University of Pittsburgh School of Medicine for 18 years prior to his arrival in Phoenix in 2011. Dr. Bowser is also co-Founder of Knopp Biosciences, LLC and Iron Horse Diagnostics, Inc., biotechnology companies advancing new treatments and ways to diagnose neurologic disorders. Iron Horse Diagnostics is commercializing the first diagnostic test for ALS. Dr. Bowser's research interests are to determine the molecular and cellular basis of motor neuron cell death in ALS and translate these findings to the clinic. His laboratory leads efforts in the discovery and validation of protein biomarkers for ALS. Dr. Bowser also pursues methods to monitor ALS disease progression and drug effects during clinical trials. He has national and international leadership positions in the field of ALS, and co-Chairs a national ALS Biorepository, providing biofluid and tissue samples collected using standardized procedures to ALS investigators throughout the country.

Research

Dr. Bowser's research interests are to determine the molecular and cellular basis of motor neuron cell death in ALS and translate these findings to the clinic. His laboratory leads efforts in the discovery and validation of protein biomarkers for ALS. Dr. Bowser also pursues methods to monitor ALS disease progression and drug effects during clinical trials. He has national and international leadership positions in the field of ALS, and co-Chairs a national ALS Biorepository, providing biofluid and tissue samples collected using standardized procedures to ALS investigators throughout the country.